You are in: Home > Articles > 20th July 2008 > Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)
20th July 2008 at 15:07 BST by Dr.C.A.Jenner MB BS, FRCA. Permalink.
Article on Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)
The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale is an assessment tool used by the medical community to analyze and classify pain.
In other words, it is a simple bedside test, conducted in two parts .i.e. a patient-completed questionnaire and a brief clinical assessment.
The primary purpose of this test is to assess whether the pain experienced is predominantly due to nerve damage or not. The LANSS scale is the only published tool with validity for discriminating between neuropathic and nociceptive pain, regardless if the disease-based diagnostic methods.
However, it important to note that the purpose of this test is to assist the clinicians in assessing the severity of the pain or its causes.
The Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS) comprises of a 7-item pain scale, including the sensory descriptors and items for sensory examination.
Out of the seven items in the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS), five are symptom related and two are examination items. For the reader's benefit, we have furnished this list in the further sections.
In addition to the original LANSS pain scale, a modified S-LANSS or self-report LANSS test is also available that can be used by patients in the absence of a clinician.
According to various research reports, these LANSS tests correctly classified the patients as suffering from nociceptive and neuropathic pain, in four out of every five patients experiencing chronic pain.
Research reports strongly support the use of the LANSS pain scale for the classification of chronic pain.
In a recent study conducted to analyze the efficacy and accuracy of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale, it was found that the LANSS scale correctly identified 11 of 13 with the accurate category of neuropathic pain.
In this section, we have listed the 7-step questionnaire used a part of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale, along with suitable interpretations.
Both of the tests .i.e. LANSS and S-LANSS result in the patient being scored out of a total of 24. A patient with a score of 12 or more on this scale is diagnosed as suffering from neuropathic pain to some degree.
The above score can be used to assess the type of pain, whether it is neuropathic pain or not and also to assess your response to the treatment over a specific period of time.
The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) has been found highly result-oriented and accurate in its assessments. However, experts suggest that there is still a small chance that a patient with a score below 12 on the scale might also be suffering from neuropathic pain. Similarly, a patient with a score of more than 12 might not be suffering from neuropathic pain.
Therefore, it is important that medical consultation is taken to confirm and verify the diagnosis made by the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale as well as the S-LANSS scale.
‘Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)’ was posted by Dr.C.A.Jenner MB BS, FRCA on 20th July 2008 at 15:07 BST and filed under neuropathic pain.
Subscribe to RSS for Articles . What is RSS?
.jpg)
© London Pain Consultants 2006. Telephone: 0845 045 0250.